Skip to content

Reactive balance training to improve balance control and reduce falls in older adults: a randomized controlled trial.

Reactive balance training to improve balance control and reduce falls in older adults: a randomized controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25249
Enrollment
80
Registered
2019-04-17
Start date
2019-03-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No specific diseases

Interventions

Three weeks of reactive balance training (3x30 minutes) on the Computer Assisted Rehabilitation Environment (CAREN, Motek). The training consists of gait adaptability, and reactive balance training du

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Community-dwelling older adults (age 65 or older) who recently experienced a fall (past 3 months) and are able to walk 15+ minutes without aid.

Exclusion criteria

Exclusion criteria: Falls caused by third parties or during sports activities, recent fracture or severe contusion to the lower extremities or back, use of medication known to increase fall risk (antidepressants, benzodiazepines, sedatives, hypnotics, antipsychotics), diagnosed with osteoporosis, any disease or disorder that may influence the safety of training, inability to follow intructies or provide written informed consent in Dutch.

Design outcomes

Primary

MeasureTime frame
The primary outcome is balance control measured with the mini BESTest.

Secondary

MeasureTime frame
Secondary outcomes are daily-life falls incidence (prospective, 6 months), fear of falling (FES-I) and long-term injurious falls incidence (24 months). Edit: Also the acceptability of the reactive balance training program will be evaluated through semi-structured interviews in a sample of subjects from the intervention group.

Contacts

Public ContactMarissa Gerards

MUMC+

marissa.gerards@mumc.nl043-3877146

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)